Skip to content

Drug interactions

Nilutamide + Paclitaxel protein bound

Severity: Minor

Nilutamide and Paclitaxel protein bound: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nilutamide may weakly inhibit CYP3A4 and CYP2C8 pathways involved in paclitaxel clearance, which could modestly increase paclitaxel exposure. The clinical significance is likely small.

What this interaction means in plain words

Nilutamide and Paclitaxel protein bound have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Nilutamide may weakly inhibit CYP3A4-mediated metabolism of paclitaxel.

What to do

Monitor for increased neutropenia and neuropathy. No routine dose adjustment is needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilutamide and Paclitaxel protein bound, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nilutamide with Paclitaxel protein bound?

MediHelp rates the interaction as minor. Nilutamide and Paclitaxel protein bound have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Nilutamide may weakly inhibit CYP3A4 and CYP2C8 pathways involved in paclitaxel clearance, which could modestly increase paclitaxel exposure. The clinical significance is likely small.

How serious is the interaction between Nilutamide and Paclitaxel protein bound?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for increased neutropenia and neuropathy. No routine dose adjustment is needed.

What other medicines interact with Nilutamide?

MediHelp also lists interactions of Nilutamide with, for example, Dihydroergotamine intranasal, Mavacamten, Artemether / lumefantrine. The full list is on the Nilutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in